(continued)
- Cablivi (caplacizumab-yhdp)
- Anagrelide (Agrylin)
- Wilate (Antihemophilic Factor/von Willebrand Factor Complex)
- Humate P (Antihemophilic Factor/von Willebrand Factor Complex)
- Alphanate (Antihemophilic factor/von Willebrand Factor Complex)
- Takhzyro (Lanadelumab-Flyo)
- Palynziq (Pegvaliase-Pqpz)
- Sapropterin (Javygtor, Kuvan)
- Kalbitor (ecallantide)
- Ruconest (C1 esterase inhibitor, recombinant)
- Hemofil M (antihemophilic factor, human)
- Esperoct (antihemophilic factor, recombinant)
- AlphaNine SD (Coagulation Factor IX, Human)
- Profilnine (Factor IX Complex)
- Beovu (Brolucizumab)
- Cosentyx (secukinumab)
- Octreotide (Sandostatin, Bynfezia)
- Mycapssa (Octreotide)
- Tiopronin (Thiola)
- Siliq (brodalumab)
- C1 Esterase Inhibitor (Human) (Cinryze, Haegarda)
- Berinert (C1 Esterase Inhibitor, Human)
- Icatibant (Firazyr, Sajazir)
- Lanreotide (Somatuline Depot)
- Iwilfin (Eflornithine)
- Lithostat (acetohydroxamic acid)
- Oxlumo (lumasiran)
- Zokinvy (lonafarnib)
- Signifor (pasireotide)
- Aranesp (darbepoetin alfa)